Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Opa-Locka, Florida Clinical Trials

A listing of Opa-Locka, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (1134) clinical trials

Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

Study duration per participant is approximately 27 to 51 months, assuming approximately 24 months of recruitment, and approximately 27 months of follow-up after the last patient is randomized.

Phase

0.0 miles

Learn More »

Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee Hip or Shoulder Replacement

A4091064 is a long-term observational follow up study of subjects from tanezumab interventional studies A4091056, A4091057 or A4091058.

Phase

0.55 miles

Learn More »

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

All subjects will receive induction therapy of IV gemcitabine plus nab-paclitaxel, as well as radiation therapy for approximately four months. Subjects who remain eligible will then be randomized to receive either intra-arterial chemotherapy with gemcitabine; or to continue gemcitabine plus nab-paclitaxel. Subjects will receive the randomized treatments for up to ...

Phase

1.55 miles

Learn More »

Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)

This is a multicenter, randomized, open-label, active-controlled Phase 3 study of the efficacy and safety of vadadustat versus darbepoetin alfa for the correction or maintenance treatment in subjects with anemia secondary to CKD who have recently initiated dialysis treatment for end-stage renal disease.

Phase

2.76 miles

Learn More »

Phase 2 Dose-finding IMU-838 for Ulcerative Colitis

The investigational medicinal product (IMP) IMU-838 (vidofludimus calcium) is a new compound that selectively inhibits the human enzyme dihydroorotate dehydrogenase (DHODH). Dihydroorotate dehydrogenase plays a major role in the de-novo pyrimidine synthesis and is specifically expressed at high levels in proliferating or activated lymphocytes. Resting lymphocytes satisfy their pyrimidine requirements ...

Phase

3.08 miles

Learn More »

Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids Inclusion Criteria for Double-Blind and Recurrence Males or non-pregnant females, aged ≥ 18 to ≤ 75 years. Symptomatic internal hemorrhoids, Grades I-III by direct anoscopic visualization (anoscopic visualization not required if Grade determined by colonoscopy within 28 days prior ...

Phase

3.27 miles

Learn More »

Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain Patient Inclusion Criteria: Male and female subjects ≥ 18 years of age with moderate to severe, chronic low back pain (lasting at least several hours daily) as their ...

Phase

3.27 miles

Learn More »

A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk. Eligibility: Ages Eligible for Study: 40 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No Patient Inclusion Criteria: ...

Phase N/A

3.27 miles

Learn More »

Many people struggle to control their high blood pressure, a disease known as hypertension. New medical treatments can be a way to make high blood pressure easier to control. Medical research works towards finding those new treatments. You will be taking a combination of study medications or a single type ...

Phase

3.27 miles

Learn More »

Adults who have sprained or strained an ankle in the last 48 hours are needed to help evaluate an investigational patch to see if it helps relieve pain. This medical research study is evaluating an investigational patch that is applied to a sprained or strained ankle every 12 hours for ...

Phase N/A

3.27 miles

Learn More »